7 completed, 3 recruiting, 3 unknown, 1 terminated. 6 Phase 2, 2 Not applicable, 2 Phase 4, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Terminated 1, Withdrawn 1 |
| Not applicable | 2 | Unknown 2 |
| Phase 4 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Autologous Stem Cell Transplantation: new trials by email Literature Review of Autologous Stem Cell Transplantation trials Research Report on Autologous Stem Cell Transplantation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation Daratumumab, Lenalidomide, Bortezomib - Newly Diagnosed Multiple Myeloma, Multiple Myeloma | Phase 2 | Withdrawn | UNC Lineberger Comprehensive Cancer Center | 2026-07-01 | 2026-06-09 | |
| Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan Olanzapine - Multiple Myeloma, Autologous Stem Cell Transplantation | Phase 3 | Recruiting | Augusta University | 172 | 2024-09-17 | 2024-11-22 |
| Clinical Study of CAR-T Cell Therapy Following ASCT for R/R B-cell Non-Hodgkin's Lymphoma Apheresis, Autologous Stem Cell Transplantation, CAR-T Cell Therapy - Lymphoma, B-Cell, Autologous Stem Cell Transplantation | Phase 2 | Terminated | The First Affiliated Hospital of Soochow University | 8 | 2024-01-01 | 2026-06-05 |
| Modified BEAM Regimen for T Cell Lymphoma Underwent ASCT modified BEAM, BEAM - Autologous Stem Cell Transplantation, Conditioning | Not applicable | Unknown | First Affiliated Hospital Xi'an Jiaotong University | 122 | 2023-04-15 | 2023-04-18 |
| Daratumumab-containing Induction Effects on Stem Cells Mobilization, colLection and Engraftment in Newly Diagnosed Multiple MyelomA Patients. Daratumumab - Multiple Myeloma, Daratumumab | Completed | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 188 | 2022-01-01 | 2025-08-15 | |
| Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis Upfront autologous HSCT - Systemic Sclerosis, Systemic Scleroses, Diffuse | Phase 4 | Completed | UMC Utrecht | 60 | 2020-09-17 | 2026-03-24 |
| Pedometer Activity Monitoring After ASCT Pedometer-based activity monitoring after ASCT - Lymphoma, Myeloma | Phase 2 | Completed | Insel Gruppe AG, University Hospital Bern | 62 | 2017-11-02 | 2023-04-03 |
| Microtransplantation Versus Auto-SCT in ≥PR Multiple Myeloma Patients stem cell transplantation - Microtransplantation, Autologous Stem Cell Transplantation | Not applicable | Unknown | Chen Wenming | 80 | 2016-01-01 | 2016-12-16 |
| Stem Cell Harvesting Using GCSF Plus Plerxiafor, in First -Line, for Heavily Pre- Treated Pediatric Oncology Patients. Plerixafor - Autologous Stem Cell Transplantation | Phase 4 | Unknown | Tel-Aviv Sourasky Medical Center | 30 | 2014-02-01 | 2013-12-10 |
| Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells - Scleroderma, Cardiac Involvement | Phase 2 | Completed | University Hospital Tuebingen | 44 | 2012-09-01 | 2024-07-29 |
| Mozobil for Autologous Stem Cell Mobilization Plerixafor - Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma | Phase 2 | Completed | Sheba Medical Center | 20 | 2010-06-01 | 2015-12-03 |
| NOX-A12 First-in-human (FIH) Study NOX-A12 - Autologous Stem Cell Transplantation | Phase 1 | Completed | TME Pharma AG | 48 | 2009-10-01 | 2014-06-26 |
| AMD3100 (Plerixafor) With G-CSF in Poor Mobilizing Adult Patients Who Previously Failed Hematopoietic Stem Cell (HSC) Collection/Attempts G-CSF plus plerixafor - Autologous Stem Cell Transplantation | Phase 2 | Completed | Genzyme, a Sanofi Company | 100 | 2005-10-01 | 2014-03-13 |
| CIBMTR Research Database Autologous Stem Cell Transplantation, Allogeneic Stem Cell Transplantation | Recruiting | Center for International Blood and Marrow Transplant Research | 99999999 | 2002-07-01 | 2025-08-12 | |
| Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries Autologous Stem Cell Transplantation, Allogeneic Stem Cell Transplantation | Recruiting | Center for International Blood and Marrow Transplant Research | 99999999 | 1991-07-01 | 2023-05-03 |
Multiple Myeloma (5) · Lymphoma, Non-Hodgkin (2) · Scleroderma, Diffuse (2) · Hematologic Neoplasms (1) · Hodgkin Disease (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Nausea (1) · Neoplasms, Plasma Cell (1) · Scleroderma, Systemic (1)
Hemic and Lymphatic Diseases (9) · Neoplasms (9) · Immune System Diseases (8) · Immunoproliferative Disorders (8) · Lymphoproliferative Disorders (8) · Neoplasms by Histologic Type (8) · Hematologic Diseases (6) · Blood Protein Disorders (5) · Cardiovascular Diseases (5) · Hemorrhagic Disorders (5) · Hemostatic Disorders (5) · Neoplasms, Plasma Cell (5) · Paraproteinemias (5) · Vascular Diseases (5) · Lymphatic Diseases (4)
plerixafor (3) · daratumumab (2) · Antigens, Differentiation (1) · Blood Component Removal (1) · Bortezomib (1) · Carmustine (1) · Cytarabine (1) · Dexamethasone (1) · Etoposide (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Immunotherapy, Adoptive (1) · Lenalidomide (1) · Melphalan (1) · NOX-A12 (1)
Center for International Blood and Marrow Transplant Research (2) · Augusta University (1) · Chen Wenming (1) · First Affiliated Hospital Xi'an Jiaotong University (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Genzyme, a Sanofi Company (1) · Insel Gruppe AG, University Hospital Bern (1) · Sheba Medical Center (1) · TME Pharma AG (1) · Tel-Aviv Sourasky Medical Center (1) · The First Affiliated Hospital of Soochow University (1) · UMC Utrecht (1) · UNC Lineberger Comprehensive Cancer Center (1) · University Hospital Tuebingen (1)
United States (5) · China (3) · Germany (2) · Italy (2) · Israel (1) · Netherlands (1) · Switzerland (1) · United Kingdom (1)
Arnon Nagler, MD (1) · Deipei Wu, M.D. (1) · Jacob M van Laar, MD PhD (1) · Joerg C Henes, MD (1) · Julia Spierings (1) · Luciana Teofili (1) · Menachem Bitan, MD (1) · Patricia Steinert, PhD, MBA (1) · Samuel M Rubinstein, MD, MSCI (1) · Stefan Zeitler, MD (1) · Stephen Spellman (1) · Thomas Pabst, MD (1) · Wenming Chen, doctor (1) · Xiaoning Wang (1)